Nov 10 (Reuters) -
* Citron Research's Andrew Left on CNBC- Acthar poster child for price gouging
* Citron Research's Andrew Left on CNBC- " Mallinckrodt (N:MNK) is not Valeant; it is
worse"
* Citron Research's Andrew Left on CNBC- Mallinckrodt CEO Trudeau
misrepresenting the efficacy of Acthar
* Citron research's Andrew Left on CNBC- "I have been short on Mallinckrodt on
and off for nearly four years"
* Citron research's Andrew Left on CNBC-"I am going to want to see what will be
up in the next few quarters for Valeant"
* Citron research's Andrew Left on CNBC- "My short on Valeant has been
significantly scaled down from where it was earlier"